Apnimed, Inc. APMD
IPO
NASDAQ
| 06/30/2026 | 03/31/2026 | 06/30/2025 | |||
|---|---|---|---|---|---|
| Revenue | 12.08M | 84.81M | 17.11M | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | 12.08M | 84.81M | 17.11M | ||
| Cost of Revenue | 1.21M | 2.16M | 1.72M | ||
| Gross Profit | 10.87M | 82.65M | 15.39M | ||
| SG&A Expenses | 12.67M | 6.51M | 5.35M | ||
| Depreciation & Amortization | -- | -- | -- | ||
| Other Operating Expenses | -- | -- | -- | ||
| Total Operating Expenses | 23.78M | 16.77M | 23.05M | ||
| Operating Income | -11.70M | 68.04M | -5.94M | ||
| Income Before Tax | 126.11M | 70.37M | -5.63M | ||
| Income Tax Expenses | -- | -- | -- | ||
| Earnings from Continuing Operations | 126.11M | 70.37M | -5.63M | ||
| Earnings from Discontinued Operations | -178.00K | -2.65M | -63.85M | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -- | -- | -- | ||
| Net Income | 125.94M | 67.72M | -69.47M | ||
| EBIT | -11.70M | 68.04M | -5.94M | ||
| EBITDA | -11.70M | 68.05M | -5.93M | ||
| EPS Basic | 26.25 | 12.45 | -14.61 | ||
| Normalized Basic EPS | 16.74 | 7.85 | -0.74 | ||
| EPS Diluted | 3.92 | 1.52 | -14.61 | ||
| Normalized Diluted EPS | 2.48 | 0.99 | -0.74 | ||
| Average Basic Shares Outstanding | 4.80M | 5.44M | 4.75M | ||
| Average Diluted Shares Outstanding | 32.35M | 43.07M | 4.75M | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||